RENAL-TRANSPLANTATION IN PATIENTS MORE TH AN 60 YEARS OLD - ANALYSIS OF A 57 PATIENTS EXPERIENCE IN A SINGLE-CENTER

From April 1988 to August 1993, 57 elderly recipients more than 60 yea rs old (mean age 64+/-3 years, 35 males, 22 females) underwent cadaver ic renal transplantation. The pretransplant screening included immunol ogical and viral status and urological examination; cardiovascular ris k factors were systematically estimated by medical history, physical e xamination, echocardiography, femoral arterial doppler, and myocardial stress thallium imaging. A coronarography was performed if myocardial ischemia was evidenced. Patients free of cardiovascular diseases or a fter correction of Vascular and/or coronary lesions were included in t he waiting list. A sequential immunosuppression regimen including azat hioprine, prednisolone anad antilymphocyte globulins was given in all patients. Oral cyclosporin A (5-8 mg/kg/day) was started when serum cr eatinine level decreased to 200 mu mol/l; antilymphocyte globulins wer e slopped when whole trough blood cyclosporin level reached 150-200 ng /ml. After 24 months of follow-up, the patient survival rate of elderl y recipients was significantly lower than the survival rate observed i n patients less than 60 years old (90% vs 97%; p<0,005); the deaths we re related to cardiovascular complications in 3 cases and to infectiou s diseases-in 3 cases. No abdominal complications were observed in our series. The graft survival was identical in both groups (81% vs 82% a t 2 years), and we observed a low incidence of acute rejection (23%) i n the elderly group. The graft function, as determined by serum creati nine level, is significantly correlated with the donor age (p<0,05). W e conclude that the patients more than 60 years old, free of ischemic coronary disease or after correction of such a lesion could be safely transplanted. We suggest that kidneys from old donors should be harves ted and given to those elderly recipients.